Prevalence of and risk factors for primary aldosteronismamong patients with resistant hypertension in China

Journal of Hypertension

Volumn 31, Issue 7, 2013, Pages 1465-1472

  Sang, Xiaojing ^a   Jiang, Yiran ^a   Wang, Weiqing ^a   Yan, Li ^b   Zhao, Jiasheng ^c   Peng, Yongde ^d   Gu, Wei ^e   Chen, Gang ^f   Liu, Wei ^g   Ning, Guang ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

^d SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^e ZHEJIANG UNIVERSITY   (China)

^f FUJIAN MEDICAL UNIVERSITY   (China)

^g SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Essential; Hyperaldosteronism; Hypertension; Metabolism; Population; Primary; Renin Angiotensin system

Indexed keywords

ALDOSTERONE; POTASSIUM;

ADULT; ALCOHOL CONSUMPTION; ALDOSTERONE BLOOD LEVEL; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CHINA; CHINESE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FAMILY HISTORY; FEMALE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; ONSET AGE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RESISTANT HYPERTENSION; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 84880027325     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328360ddf6     Document Type: Article

References (29)

1. Rossi GP. Prevalence and diagnosis of primary aldosteronism. Curr Hypertens Rep 2010; 12:342-348.
2. Conn JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955; 45:3-17.
3. Monticone S, Viola A, Tizzani D, Crudo V, Burrello J, Galmozzi M, et al. Primary aldosteronism: who should be screened? Horm Metab Res 2012; 44:163-169.
4. David AC. Is there an unrecognized epidemic of primary aldosteronism? (Pro) Hypertension 2007; 50:447-453.
5. Li L, Rao K, Kong L, Yao C, Xiang H, Zhai F, et al. 2002 Investigation of Nutritional and healthy status in Chinese population. J Epidemiol 2005; 7 (Chinese):478-484.
6. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008; 371:1921-1926.
7. Funder JW, Carey RW, Fardella C, Gomez-Sanchez CE, Manterou F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93:3266-3281.
8. Omura M, Saito J, Yamaguchi K, Gomez-Sanchez CE, Kakuta Y, Nishikawa T, et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004; 27:193-202.
9. Preti P, Jansen PM, Boomsma F, van den Meiracker AH. Aldosteroneto-renin ratio as a screening test for primary aldosteronism -The Dutch ARRAT Study. Neth J Med 2008; 66:220-228.
10. Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellin A. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res 2007; 30:111-117.
11. Mosso L, Carvajal C, González A, Barraza A, Avila F, Montero J, et al. Primary aldosteronism and hypertensive disease. Hypertension 2003; 2:161-165.
12. Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C, et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab 2006; 91:2618-2623.
13. Tiu SC, Choi CH, Shek CC, Ng YW, Chan FK, Ng CM, Kong AP. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 2005; 90:72-78.
14. Hasties TJ, Tibshirani RJ. Generalized additive models. New York: Chapman and Hall; 1990.
15. Strauch B, Zelinka T, Hampf M, Bernhardt R, Widimsky J Jr., Ng CM, Kong AP. Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 2003; 17:349-352.
16. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004; 136:1227-1235.
17. Nwariaku FE, Miller BS, Auchus R, Holt S, Watumull L, Dolmatch B, et al. Snyder 3rdWH2006 Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg 2006; 141:497-502.
18. Herpin D, Sosner P, Amar J, Chamontin B. Investigation of hyperaldosteronism in the hypertensive patient. Why? When? How? Arch Mal Coeur Vaiss 2003; 96:37-42.
19. Akpunonu BE, Mulrow PJ, Hoffman EA. Secondary hypertension: evaluation and treatment. Dis Mon 1996; 42:609-722.
20. Viera AJ, Neutze DM. Diagnosis of secondary hypertension: an agebased approach. Am Fam Physician 2010; 82:1471-1478.
21. Stowasser M, Gordon RD. Primary aldosteronism: careful investigation is essential and rewarding. Mol Cell Endocrinol 2004; 217:33-39.
22. Mulatero P, Dluhy RG, Giachetti G, Boscaro M, Veglio F, Stewart PM. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab 2005; 16:114-119.
23. Anderson CA, Appel LJ, Okuda N, Brown IJ, Chan Q, Zhao L, et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc 2010; 110:736-745.
24. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 2001; 37:699-705.
25. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89:1045-1050.
26. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85:2854-2859.
27. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 2007; 66:607-618.
28. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002; 40:897-902.
29. Nishizaka MK, Pratt-Ubunama M, Zaman MA, Cofield S, Calhoun DA. Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. Am J Hypertens 2005; 18:805-812.